CDKN2A and mesothelioma: Approximately 10% of mesothelioma patients harbor germline mutations in cancer susceptibility genes, predominantly involving CDKN2A, neurofibromatosis type 2 (NF2), and BRCA1‐associated protein 1 (BAP1) [16].